InsiderSignal.AI

InsiderSignal.ai

PEN - Penumbra Inc

Insider Sale by Grewal Harpreet (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Grewal Harpreet, serving as Dir at Penumbra Inc (PEN), sold 100 shares at $328.22 per share, for a total transaction value of $32,822.00. Following this transaction, Grewal Harpreet now holds 8,719 shares of PEN.

This sale represents a 1.00% decrease in Grewal Harpreet's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 4 days after the trade was made.

Penumbra Inc operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Grewal Harpreet

Dir

Harpreet S. Grewal is an accomplished executive and director serving as an Independent Director on the Board of Penumbra, Inc. (NYSE: PEN) since April 2015.[[1]](https://www.gurufocus.com/insider/39299/harpreet-grewal)[[2]](https://www.marketscreener.com/insider/HARPREET-GREWAL-A03NHC/)[[7]](https://www.penumbrainc.com/investors/governance/) He owns approximately 8,230 shares of Penumbra stock, valued at over $2.5 million as of early 2026, following recent sales including 186 shares on January 6, 2026, at $312.64 per share under a Rule 10b5-1 plan.[[3]](https://www.marketbeat.com/instant-alerts/penumbra-nysepen-director-harpreet-grewal-sells-186-shares-2026-01-08/)[[4]](https://www.investing.com/news/insider-trading-news/grewal-penumbra-director-sells-58151-in-stock-93CH-4438379)[[5]](https://www.stocktitan.net/sec-filings/PEN/form-4-penumbra-inc-insider-trading-activity-0093be8bcbf1.html) Grewal previously held the role of EVP and CFO at Constant Contact Inc. (CTCT) and Cimpress PLC (CMPR), demonstrating extensive experience in finance and operations.[[1]](https://www.gurufocus.com/insider/39299/harpreet-grewal) Currently, Harpreet Grewal is the Founding Partner and CEO of 123G LLC, and serves in other capacities such as Director at Augmented Reality Concepts, Inc., Member of the Advisory Board at PadinMotion, Inc. since 2013, and Operating Advisor at Wavecrest Management Co LLC.[[2]](https://www.marketscreener.com/insider/HARPREET-GREWAL-A03NHC/)[[7]](https://www.penumbrainc.com/investors/governance/) His board service at Penumbra, a global healthcare company focused on innovative medical devices for neurovascular and peripheral vascular conditions, underscores his expertise in technology services, consumer services, and commercial sectors.[[2]](https://www.marketscreener.com/insider/HARPREET-GREWAL-A03NHC/)[[3]](https://www.marketbeat.com/instant-alerts/penumbra-nysepen-director-harpreet-grewal-sells-186-shares-2026-01-08/)

View full insider profile →

Trade Price

$328.22

Quantity

100

Total Value

$32,822.00

Shares Owned

8,719

Trade Date

Thursday, April 2, 2026

7 days ago

SEC Filing Date

Monday, April 6, 2026

Filed 4 days after trade

HEALTHCAREMEDICAL DEVICES

About Penumbra Inc

Company Overview

No company information available
View news mentioning PEN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5424751

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime